About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Chroma™
Sofra™
mRNA Vaccines
Autoimmune Disease
Clinical Trials
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
23 Dec 2020
Federal Government Approved Future Overseas R&D Expenditure
15 Dec 2020
Cleansing Notice
15 Dec 2020
Appendix 2A
15 Dec 2020
Change of Director's Interest Notice - BP
15 Dec 2020
Change of Director's Interest Notice - FB
15 Dec 2020
Appendix 3G
11 Dec 2020
December Investor Webinar Recording
10 Dec 2020
Change in substantial holding
10 Dec 2020
Cleansing Notice
10 Dec 2020
Appendix 2A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
